To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene FBXO33TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
170 supporting clones for gene FBXO33 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
BC030611 testis FBXO33.a 1 to 3030 6 to 3033 H331N E493K S494A I495L D496I ... tiling clone, available from MGC, AAA Possibly primed on the genome, locally A rich (36/39 A in genome downstream of last aligned base) 3028/3028
(100 %)
5 diff
(99.9 %id)
BG722889 testis FBXO33.a 3 to 837 8 to 834   available from MGC,   827/834
(99 %)
6 diff
(99.3 %id)
NM_203301.2   FBXO33.a 3 to 3851 1 to 3849 exact RefSeq,   3849/3849
(100 %)
0 diff
(100 %id)
BI460761 testis FBXO33.a 26 to 674 1 to 649       649/649
(100 %)
7 diff
(99.0 %id)
BC068566 testis FBXO33.a 31 to 3030 1 to 3000 exact tiling clone, available from MGC, AAA Possibly primed on the genome, locally A rich (36/39 A in genome downstream of last aligned base) 3000/3000
(100 %)
2 diff
(100.0 %id)
CN370853 embryonic stem cells, cell lines H1, H7, andH9 FBXO33.a 58 to 363 1 to 306       306/306
(100 %)
0 diff
(100 %id)
BI599887 brain, hypothalamus FBXO33.a 76 to 781 1 to 718       718/718
(100 %)
23 diff
(96.8 %id)
TI_45212231   FBXO33.a 81 to 781 95 to 807       713/807
(88 %)
6 diff
(99.3 %id)
DB495458 hypothalamus FBXO33.a 84 to 588 1 to 506       506/506
(100 %)
4 diff
(99.3 %id)
DB499692 hypothalamus FBXO33.a 84 to 584 1 to 501       501/501
(100 %)
3 diff
(99.5 %id)
DB499959 hypothalamus FBXO33.a 84 to 575 1 to 492       492/492
(100 %)
3 diff
(99.4 %id)
DB503369 hypothalamus FBXO33.a 84 to 557 1 to 474       474/476
(99 %)
5 diff
(99.0 %id)
TI_57202600   FBXO33.a 86 to 807 35 to 764       730/904
(80 %)
33 diff
(96.4 %id)
BC053537 Brain, Lung, Testis, adult, pooled whole FBXO33.a 87 to 3761 1 to 3676 exact tiling clone, available from MGC, AAA Possibly primed on the genome, locally A rich (26/27 A in genome downstream of last aligned base) 3676/3676
(100 %)
1 diff
(100.0 %id)
BI823599 pooled brain, lung, testis FBXO33.a 87 to 807 1 to 729       729/869
(83 %)
33 diff
(96.3 %id)
CV572501 cornea, eye FBXO33.a 88 to 647 1 to 560       560/560
(100 %)
1 diff
(99.9 %id)
BU165796 leiomyosarcoma, uterus FBXO33.a 108 to 758 1 to 654       654/916
(71 %)
20 diff
(97.9 %id)
CN370854 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells FBXO33.a 128 to 599 1 to 472       472/472
(100 %)
0 diff
(100 %id)
BX380395 Placenta Cot 25-normalized FBXO33.a 348 to 750 1 to 405       405/586
(69 %)
3 diff
(99.5 %id)
BX248772 placenta FBXO33.a 349 to 1377 1 to 1029       1029/1029
(100 %)
0 diff
(100 %id)
BX346963 Placenta Cot 25-normalized FBXO33.a 361 to 1215 1 to 856       856/858
(99 %)
22 diff
(97.5 %id)
BU508088 leiomyosarcoma, uterus FBXO33.a 361 to 1043 11 to 694       684/1194
(57 %)
17 diff
(98.6 %id)
CR995149 T-Lymphocytes FBXO33.a 369 to 669 1 to 302       302/302
(100 %)
2 diff
(99.4 %id)
CT002270 T-Lymphocytes FBXO33.a 391 to 840 1 to 450       450/451
(99 %)
1 diff
(99.8 %id)
DB441947 testis FBXO33.a 474 to 898 1 to 425       425/426
(99 %)
8 diff
(98.2 %id)
DB478988 hippocampus FBXO33.a 474 to 993 1 to 520       520/520
(100 %)
2 diff
(99.7 %id)
BF173776 blood FBXO33.a 607 to 814 1 to 207       207/210
(98 %)
15 diff
(92.9 %id)
AL040793.
matches multiple genes
testis FBXO33.a 733 to 1361 1 to 629     also hits gene PABPC3 629/629
(100 %)
0 diff
(100 %id)
DB078506 testis FBXO33.a 765 to 1333 2 to 570   capped   569/569
(100 %)
1 diff
(99.9 %id)
D60079   FBXO33.a 826 to 1291 1 to 466       466/466
(100 %)
3 diff
(99.4 %id)
BU569197 testis FBXO33.a 1032 to 1759 1 to 728       728/728
(100 %)
7 diff
(99.1 %id)
AK294140 alzheimer cortex FBXO33.a 1159 to 2726 1 to 1569       1569/1569
(100 %)
4 diff
(99.8 %id)
DC312524 alzheimer cortex FBXO33.a 1159 to 1792 1 to 635       635/635
(100 %)
1 diff
(99.9 %id)
BQ286342 Pancreas, Purified pancreatic islet FBXO33.a 1193 to 1813 1 to 621       621/621
(100 %)
0 diff
(100 %id)
CK825799 Pancreas, Purified pancreatic islet FBXO33.a 1214 to 1783 1 to 570     Submitted on the opposite strand 570/570
(100 %)
0 diff
(100 %id)
BM473108 duodenal adenocarcinoma, cell line, small intestine FBXO33.a 1250 to 1848 1 to 599       599/1093
(54 %)
4 diff
(99.7 %id)
BG778895 adenocarcinoma, Prostate FBXO33.a 1292 to 1738 224 to 683       661/696
(94 %)
48 diff
(93.2 %id)
BM459770 leiomyosarcoma, uterus FBXO33.a 1309 to 2152 19 to 867       849/886
(95 %)
24 diff
(97.3 %id)
CB114677 Liver FBXO33.a 1473 to 2070 1 to 597       597/597
(100 %)
1 diff
(99.9 %id)
CD107100 brain, Pituitary FBXO33.a 1491 to 1928 1 to 441       441/745
(59 %)
7 diff
(99.1 %id)
BC042535 Skin, squamous cell carcinoma FBXO33.a 1524 to 3761 1 to 2238   available from MGC, AAA Possibly primed on the genome, locally A rich (26/27 A in genome downstream of last aligned base) 2238/2238
(100 %)
2 diff
(100.0 %id)
BG679920 skin, squamous cell carcinoma FBXO33.a 1524 to 2352 1 to 825   available from MGC,   825/825
(100 %)
7 diff
(99.2 %id)
BF828011 head_normal FBXO33.a 1559 to 1851 30 to 321       292/321
(90 %)
7 diff
(97.9 %id)
EC584599 Prostate FBXO33.a 1589 to 1691 1 to 99       99/100
(99 %)
5 diff
(95.0 %id)
BF828008 head_normal FBXO33.a 1602 to 1851 46 to 295       250/295
(84 %)
10 diff
(96.7 %id)
DB169395 kidney, tumor tissue FBXO33.a 1625 to 2210 2 to 587   capped   586/586
(100 %)
1 diff
(99.9 %id)
CN311992 embryonic stem cells, cell lines H1, H7, andH9 FBXO33.a 1674 to 2316 1 to 643       643/643
(100 %)
7 diff
(99.0 %id)
CB137370 Liver FBXO33.a 1682 to 2142 1 to 461       461/461
(100 %)
0 diff
(100 %id)
CN264600 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells FBXO33.a 1714 to 2299 18 to 603       586/603
(97 %)
5 diff
(99.2 %id)
BG289453 bladder, transitional cell papilloma, cell line FBXO33.a 1734 to 2526 1 to 799       799/801
(99 %)
33 diff
(95.9 %id)
BF212606 bone marrow, from chronic myelogenous leukemia FBXO33.a 1786 to 2410 1 to 623       623/846
(73 %)
15 diff
(98.3 %id)
DA264029 caudate nucleus FBXO33.a 1882 to 2424 2 to 544   capped   543/543
(100 %)
0 diff
(100 %id)
AA252731   FBXO33.a 1885 to 2238 1 to 354       354/354
(100 %)
0 diff
(100 %id)
BM455686 lymph, lymphoma, cell line FBXO33.a 1938 to 2733 1 to 800   AAA   800/800
(100 %)
24 diff
(97.0 %id)
CN311991 embryonic stem cells, DMSO-treated H9 cellline FBXO33.a 2023 to 2684 1 to 662       662/662
(100 %)
1 diff
(99.9 %id)
AA037130 senescent fibroblast FBXO33.a 2070 to 2600 1 to 536       536/536
(100 %)
9 diff
(98.4 %id)
BE566297 bladder, carcinoma, cell line FBXO33.a 2132 to 2824 1 to 702       702/704
(99 %)
45 diff
(93.7 %id)
H44472 breast FBXO33.a 2152 to 2467 1 to 320       320/320
(100 %)
7 diff
(97.9 %id)
Z25893   FBXO33.a 2167 to 2551 1 to 376       376/378
(99 %)
13 diff
(96.6 %id)
BF223550 carcinoid, lung FBXO33.a 2178 to 2563 1 to 387     Submitted on the opposite strand 387/387
(100 %)
4 diff
(99.0 %id)
BQ880745 dorsal root ganglia FBXO33.a 2179 to 3059 1 to 882       882/918
(96 %)
5 diff
(99.5 %id)
FN167817 breast carcinoma FBXO33.a 2182 to 2274 1 to 92       92/92
(100 %)
2 diff
(97.9 %id)
BF668584 brain, primitive neuroectoderm FBXO33.a 2226 to 3014 1 to 769       769/848
(90 %)
54 diff
(93.7 %id)
BI857173 breast, mammary adenocarcinoma, cell line FBXO33.a 2251 to 2990 1 to 739       739/739
(100 %)
13 diff
(98.3 %id)
TI_57186836   FBXO33.a 2251 to 2990 55 to 793       739/739
(100 %)
13 diff
(98.3 %id)
BU624546 cell lines, Enchondroma FBXO33.a 2255 to 3048 791 to 1       791/791
(100 %)
2 diff
(99.8 %id)
BG577161 breast, mammary adenocarcinoma, cell line FBXO33.a 2306 to 3055 1 to 754       754/754
(100 %)
15 diff
(98.1 %id)
CV573364 cornea, eye FBXO33.a 2316 to 2917 1 to 602       602/602
(100 %)
0 diff
(100 %id)
BU618197 Cell Line, Chondrosarcoma FBXO33.a 2318 to 3030 6 to 715     Submitted on the opposite strand 710/715
(99 %)
6 diff
(99.2 %id)
AA732090 germinal center B cell FBXO33.a 2325 to 2749 1 to 425     Submitted on the opposite strand 425/425
(100 %)
1 diff
(99.8 %id)
AA804265 germinal center B cell FBXO33.a 2325 to 2760 1 to 436     Submitted on the opposite strand 436/436
(100 %)
4 diff
(99.1 %id)
BM998572 lung, Metastatic Chondrosarcoma FBXO33.a 2413 to 3055 642 to 1       642/642
(100 %)
3 diff
(99.6 %id)
BM988543 lung, Metastatic Chondrosarcoma FBXO33.a 2415 to 3055 641 to 1       641/651
(98 %)
0 diff
(100 %id)
FN131577 breast carcinoma FBXO33.a 2453 to 2536 1 to 83       83/83
(100 %)
4 diff
(95.2 %id)
W04319 lung FBXO33.a 2470 to 2839 1 to 371       371/371
(100 %)
4 diff
(99.0 %id)
TI_154153617   FBXO33.a 2482 to 3042 658 to 98   AAA Submitted on the opposite strand 561/593
(94 %)
2 diff
(99.7 %id)
EH333412   FBXO33.a 2486 to 2556 1 to 71       71/71
(100 %)
1 diff
(98.6 %id)
BU431697 lymph FBXO33.a 2503 to 3042 565 to 26   AAA Submitted on the opposite strand 540/540
(100 %)
0 diff
(100 %id)
DB374106 placenta FBXO33.a 2507 to 3042 533 to 1       533/536
(99 %)
12 diff
(97.8 %id)
AI690694 serous papillary carcinoma, high grade, 2pooled tumors, uterus FBXO33.a 2530 to 3043 514 to 1       514/514
(100 %)
0 diff
(100 %id)
BM565461 insulinoma, Pancreas FBXO33.a 2539 to 3025 487 to 1       487/487
(100 %)
0 diff
(100 %id)
N31290 melanocyte FBXO33.a 2557 to 2976 1 to 424       424/424
(100 %)
4 diff
(99.1 %id)
AW772348 Kidney FBXO33.a 2559 to 3043 485 to 1       485/485
(100 %)
0 diff
(100 %id)
DB551328 hippocampus FBXO33.a 2563 to 3042 1 to 480     Submitted on the opposite strand 480/480
(100 %)
1 diff
(99.8 %id)
AI686729 serous papillary carcinoma, high grade, 2pooled tumors, uterus FBXO33.a 2565 to 3045 481 to 1       481/487
(98 %)
0 diff
(100 %id)
BQ083791 stomach FBXO33.a 2574 to 3051 1 to 477       477/477
(100 %)
2 diff
(99.6 %id)
DB571105 hypothalamus FBXO33.a 2575 to 3042 1 to 469     Submitted on the opposite strand 469/469
(100 %)
7 diff
(98.6 %id)
DB570821 hypothalamus FBXO33.a 2581 to 3042 1 to 462     Submitted on the opposite strand 462/462
(100 %)
2 diff
(99.6 %id)
DB566517 hypothalamus FBXO33.a 2588 to 3042 1 to 455     Submitted on the opposite strand 455/455
(100 %)
1 diff
(99.8 %id)
H41838 brain FBXO33.a 2592 to 2979 1 to 397       397/397
(100 %)
10 diff
(97.5 %id)
AI708828 aorta FBXO33.a 2592 to 3010 452 to 34       419/452
(92 %)
0 diff
(100 %id)
BX093575 brain FBXO33.a 2594 to 3361 1 to 768       768/768
(100 %)
0 diff
(100 %id)
AI271547 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus FBXO33.a 2598 to 3050 451 to 1       451/451
(100 %)
4 diff
(99.2 %id)
BM991451 lung, Metastatic Chondrosarcoma FBXO33.a 2603 to 3058 458 to 3       456/458
(99 %)
0 diff
(100 %id)
AA506917 Prostate FBXO33.a 2608 to 3001 1 to 394       394/397
(99 %)
2 diff
(99.5 %id)
AI561122 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors FBXO33.a 2613 to 3043 431 to 1       431/431
(100 %)
0 diff
(100 %id)
DB547655 hippocampus FBXO33.a 2614 to 3042 1 to 429     Submitted on the opposite strand 429/429
(100 %)
0 diff
(100 %id)
DB574604 hypothalamus FBXO33.a 2614 to 3042 1 to 429     Submitted on the opposite strand 429/429
(100 %)
1 diff
(99.8 %id)
DB518179 testis FBXO33.a 2617 to 3042 1 to 426     Submitted on the opposite strand 426/426
(100 %)
0 diff
(100 %id)
AA836462 germinal center B cell FBXO33.a 2659 to 3109 450 to 2       449/450
(99 %)
0 diff
(100 %id)
DB508421 testis FBXO33.a 2661 to 3042 1 to 389     Submitted on the opposite strand 389/389
(100 %)
10 diff
(97.5 %id)
D60078   FBXO33.a 2689 to 3042 352 to 1       352/352
(100 %)
3 diff
(99.2 %id)
BM818257 stomach FBXO33.a 2700 to 3001 10 to 310       301/310
(97 %)
6 diff
(98.1 %id)
H44437 breast FBXO33.a 2701 to 3013 315 to 1       315/315
(100 %)
2 diff
(99.4 %id)
AA513198 Prostate FBXO33.a 2710 to 3043 1 to 334       334/334
(100 %)
4 diff
(98.9 %id)
N22902 melanocyte FBXO33.a 3207 to 3768 587 to 1       587/592
(99 %)
31 diff
(94.8 %id)
DB306777 caudate nucleus FBXO33.a 3311 to 3839 529 to 1   tiling clone,   529/529
(100 %)
1 diff
(99.9 %id)
N74152 lung FBXO33.a 3487 to 3768 286 to 1       286/289
(98 %)
4 diff
(98.7 %id)
BI524116 pooled lung and spleen FBXO33.b 1 to 677 1 to 702 L2C F3S L4C S5Q V6C ... tiling clone,   702/706
(99 %)
44 diff
(93.8 %id)
TI_44158724   FBXO33.b 1 to 677 62 to 764 A18S G19R A20G A21R R25A ... tiling clone,   703/768
(91 %)
15 diff
(98.1 %id)
BM507191 insulinoma, Pancreas FBXO33.b 285 to 818 1 to 534   tiling clone,   534/534
(100 %)
2 diff
(99.7 %id)
BI524705 pooled lung and spleen FBXO33.b 993 to 1854 876 to 1   tiling clone,   876/975
(89 %)
27 diff
(97.3 %id)
TI_44158725   FBXO33.b 993 to 1854 876 to 1       876/975
(89 %)
27 diff
(97.3 %id)
AW971136   FBXO33.b 1572 to 1934 109 to 471   tiling clone,   363/537
(67 %)
6 diff
(98.9 %id)
EH334794   FBXO33.b 1682 to 1747 1 to 65       65/65
(100 %)
1 diff
(98.5 %id)
FN116318 breast carcinoma FBXO33.b 1712 to 1761 1 to 51       51/52
(98 %)
2 diff
(96.2 %id)
AI253650 Prostate FBXO33.b 1732 to 1890 159 to 1       159/159
(100 %)
0 diff
(100 %id)
AI219242 placenta FBXO33.b 1744 to 1967 224 to 1       224/224
(100 %)
0 diff
(100 %id)
TI_149307848   FBXO33.b 1874 to 2628 847 to 93   tiling clone, AAA Possibly primed on the genome, locally A rich (26/27 A in genome downstream of last aligned base) 755/996
(75 %)
6 diff
(99.4 %id)
BE468249 carcinoid, lung FBXO33.b 1875 to 2290 50 to 465     Submitted on the opposite strand 416/465
(89 %)
6 diff
(98.8 %id)
BM979476 lung, Primary Lung Epithelial Cells FBXO33.b 1908 to 2628 739 to 19   AAA Possibly primed on the genome, locally A rich (26/27 A in genome downstream of last aligned base) 721/721
(100 %)
0 diff
(100 %id)
BF081196 amnion_normal FBXO33.b 1909 to 2233 327 to 1       327/403
(81 %)
6 diff
(98.6 %id)
EL950057 eyeball FBXO33.b 1919 to 2163 1 to 248       248/248
(100 %)
7 diff
(97.2 %id)
W94400 heart FBXO33.b 1921 to 2196 1 to 276       276/276
(100 %)
8 diff
(97.2 %id)
BQ187533 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid FBXO33.b 1936 to 2627 1 to 693   fully sequenced, AAA Possibly primed on the genome, locally A rich (26/27 A in genome downstream of last aligned base) 693/693
(100 %)
4 diff
(99.5 %id)
BF799239 colon_ins FBXO33.b 1962 to 2097 136 to 1     Submitted on the opposite strand 136/136
(100 %)
4 diff
(97.1 %id)
BI597398 brain, hypothalamus FBXO33.b 1970 to 2668 1 to 697       697/697
(100 %)
10 diff
(98.6 %id)
BI597406 brain, hypothalamus FBXO33.b 1970 to 2708 1 to 735       735/760
(96 %)
14 diff
(98.2 %id)
TI_45209410   FBXO33.b 1974 to 2668 90 to 782       693/782
(88 %)
6 diff
(99.3 %id)
TI_45209418   FBXO33.b 1974 to 2708 126 to 856       731/919
(79 %)
12 diff
(98.7 %id)
W01559 lung FBXO33.b 1977 to 2419 1 to 452   fully sequenced,   452/452
(100 %)
7 diff
(98.5 %id)
BQ775793 Bone, Human Chondrosarcoma Cell Line FBXO33.b 1991 to 2628 656 to 19   AAA Possibly primed on the genome, locally A rich (26/27 A in genome downstream of last aligned base) 638/638
(100 %)
0 diff
(100 %id)
BE926070 breast_normal FBXO33.b 2007 to 2099 102 to 10       93/114
(81 %)
0 diff
(100 %id)
BQ020538 Fibrosarcoma FBXO33.b 2081 to 2699 637 to 19   AAA Possibly primed on the genome, locally A rich (26/27 A in genome downstream of last aligned base) 619/619
(100 %)
0 diff
(100 %id)
DB367154   FBXO33.b 2101 to 2630 533 to 1       533/533
(100 %)
9 diff
(98.4 %id)
AI608739 normal gingiva (cell line from immortalizedkeratinocytes) FBXO33.b 2107 to 2628 522 to 1       522/522
(100 %)
0 diff
(100 %id)
AA919108 2 pooled tumors (clear cell type), Kidney FBXO33.b 2127 to 2629 510 to 8       503/510
(98 %)
0 diff
(100 %id)
AI669854 Prostate FBXO33.b 2138 to 2629 493 to 2       492/493
(99 %)
0 diff
(100 %id)
BE326645 Kidney FBXO33.b 2139 to 2629 498 to 8       491/498
(98 %)
0 diff
(100 %id)
AI094097 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus FBXO33.b 2154 to 2629 477 to 1       477/477
(100 %)
1 diff
(99.8 %id)
H96508 melanocyte FBXO33.b 2161 to 2628 473 to 2       472/479
(98 %)
0 diff
(100 %id)
DB517352 testis FBXO33.b 2163 to 2628 1 to 466     Submitted on the opposite strand 466/466
(100 %)
0 diff
(100 %id)
BF222306 Prostate FBXO33.b 2185 to 2628 444 to 1       444/444
(100 %)
1 diff
(99.8 %id)
AW195521 Kidney FBXO33.b 2189 to 2691 527 to 24   AAA   504/512
(98 %)
0 diff
(100 %id)
BE674546 carcinoid, lung FBXO33.b 2207 to 2700 498 to 5       494/498
(99 %)
0 diff
(100 %id)
AI539341 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus FBXO33.b 2213 to 2700 492 to 5       488/492
(99 %)
0 diff
(100 %id)
BQ185585 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid FBXO33.b 2215 to 2628 432 to 19   fully sequenced, AAA Possibly primed on the genome, locally A rich (26/27 A in genome downstream of last aligned base) 414/414
(100 %)
0 diff
(100 %id)
AI207351 Kidney FBXO33.b 2217 to 2629 413 to 1       413/413
(100 %)
0 diff
(100 %id)
AI150979 heart FBXO33.b 2231 to 2629 403 to 5       399/403
(99 %)
0 diff
(100 %id)
CA390622 eye, RPE/choroid FBXO33.b 2235 to 2628 1 to 394   AAA Possibly primed on the genome, locally A rich (26/27 A in genome downstream of last aligned base) 394/394
(100 %)
0 diff
(100 %id)
BX330421 Placenta Cot 25-normalized FBXO33.b 2267 to 2612 351 to 1       351/364
(96 %)
33 diff
(91.0 %id)
AI023951 parathyroid gland, parathyroid tumor FBXO33.b 2267 to 2699 444 to 12   AAA Possibly primed on the genome, locally A rich (26/27 A in genome downstream of last aligned base) 433/433
(100 %)
1 diff
(99.8 %id)
BE222176 carcinoid, lung FBXO33.b 2273 to 2698 426 to 1       426/426
(100 %)
0 diff
(100 %id)
AI693807 carcinoid, lung FBXO33.b 2274 to 2699 441 to 16   AAA Possibly primed on the genome, locally A rich (26/27 A in genome downstream of last aligned base) 426/426
(100 %)
0 diff
(100 %id)
AI686111 Prostate FBXO33.b 2275 to 2629 376 to 22       355/376
(94 %)
0 diff
(100 %id)
AI695035 carcinoid, lung FBXO33.b 2275 to 2700 426 to 1       426/426
(100 %)
0 diff
(100 %id)
AI424573 Prostate FBXO33.b 2281 to 2628 351 to 1       351/351
(100 %)
3 diff
(99.2 %id)
AI867114 carcinoid, lung FBXO33.b 2284 to 2700 419 to 3       417/419
(99 %)
0 diff
(100 %id)
AI741493 pooled FBXO33.b 2287 to 2713 446 to 20   tiling clone, AAA Possibly primed on the genome, locally A rich (26/27 A in genome downstream of last aligned base) 427/427
(100 %)
2 diff
(99.6 %id)
AI869026 Prostate FBXO33.b 2290 to 2700 412 to 1       412/412
(100 %)
1 diff
(99.8 %id)
AA932164 carcinoid, lung FBXO33.b 2301 to 2698 398 to 1       398/398
(100 %)
0 diff
(100 %id)
H41800 brain FBXO33.b 2305 to 2616 326 to 13       314/326
(96 %)
0 diff
(100 %id)
AI017043 Kidney FBXO33.b 2313 to 2700 393 to 6       388/393
(98 %)
0 diff
(100 %id)
AI419294 brain, glioblastoma (pooled) FBXO33.b 2320 to 2699 414 to 35   AAA Possibly primed on the genome, locally A rich (26/27 A in genome downstream of last aligned base) 380/380
(100 %)
3 diff
(99.3 %id)
AI422021 brain, glioblastoma (pooled) FBXO33.b 2320 to 2699 399 to 20   AAA Possibly primed on the genome, locally A rich (26/27 A in genome downstream of last aligned base) 380/380
(100 %)
1 diff
(99.8 %id)
W94401 heart FBXO33.b 2358 to 2630 275 to 2       274/282
(97 %)
0 diff
(100 %id)
AW602383 breast FBXO33.b 2372 to 2540 1 to 168       168/168
(100 %)
3 diff
(98.3 %id)
AI095389 senescent fibroblast FBXO33.b 2382 to 2638 258 to 2       257/258
(99 %)
5 diff
(98.1 %id)
N71129 lung FBXO33.b 2389 to 2629 245 to 1   fully sequenced,   245/245
(100 %)
1 diff
(99.6 %id)
AI656037 pooled germ cell tumors FBXO33.b 2400 to 2710 311 to 1       311/311
(100 %)
0 diff
(100 %id)
AI989795 pooled germ cell tumors FBXO33.b 2400 to 2711 312 to 1   tiling clone,   312/312
(100 %)
0 diff
(100 %id)
C01467   FBXO33.b 2502 to 2627 1 to 127       127/147
(86 %)
1 diff
(99.4 %id)
FN142671 breast carcinoma FBXO33.b 2537 to 2627 1 to 94       94/99
(94 %)
5 diff
(95.0 %id)
DA136453 alzheimer cortex FBXO33.c-u 1 to 544 2 to 546 exact tiling clone, to resequence, capped   545/545
(100 %)
1 diff
(99.9 %id)
CR748452   FBXO33.c-u 901 to 1391 1 to 491   tiling clone,   491/491
(100 %)
0 diff
(100 %id)
AI141232 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus FBXO33.c-u 1371 to 1804 434 to 1   tiling clone,   434/434
(100 %)
1 diff
(99.8 %id)
DB301183 alzheimer cortex FBXO33.c-u 1449 to 1798 352 to 2   to resequence,   351/352
(99 %)
0 diff
(100 %id)
AI559930 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus FBXO33.c-u 1576 to 1798 223 to 1   tiling clone,   223/223
(100 %)
0 diff
(100 %id)
BG926891 cartilage Gene FBXO33, variant not shown         Suspected internal deletion, this clone was ignored    
AV698924 hepatocellular carcinoma Gene FBXO33, variant not shown         Suspected internal deletion, this clone was ignored    
BQ269693 Pancreas, Purified pancreatic islet Gene FBXO33, variant not shown         Suspected internal deletion, this clone was ignored    
? Gene Summary Gene on genome mRNA:.a, .b, .c-u Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes DCI